<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="501">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04608383</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200611</org_study_id>
    <nct_id>NCT04608383</nct_id>
  </id_info>
  <brief_title>Laparoscopy and COVID-19 Contamination</brief_title>
  <acronym>LAPCOV</acronym>
  <official_title>Laparoscopy and COVID-19 Contamination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to search the presence of the SARS-COV-2 virus (COVID19) in the&#xD;
      pneumoperitoneum of patients with a positive (or suspected) COVID19 status during a routine&#xD;
      laparoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The main objective of the study is to demonstrate the presence of SARS-COV-2 in the exsufflated gas at the end of laparoscopy.</measure>
    <time_frame>Day 1 , at the end of the surgery</time_frame>
    <description>The SARS-COV-2 will be looked for in the gas before its elimination at the end of the intervention. To this end, the PCR search will be carried out on the filter used</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary objective of the study is to demonstrate the presence of SARS-COV-2 in the peritoneal fluid during laparoscopy</measure>
    <time_frame>Day 1 , at the end of the surgery</time_frame>
    <description>SARS-COV-2 will be tested for by PCR in the peritoneal fluid collected during laparoscopy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Additional and minimal collection of products of the human body carried out during a sample for standard of care</intervention_name>
    <description>Swab of the peritoneal fluid for traces of COVID19. The collection of peritoneal fluid is a standard care practice.&#xD;
Swab from the laparoscopy filter</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Excess peritoneal fluid, usually taken during laparoscopy Exsufflation of the&#xD;
      pneumoperitoneum through a filter&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any adult requiring a laparoscopic procedure with a positive or suspected Covid19 status.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient of legal age&#xD;
&#xD;
          -  Indication for laparoscopy&#xD;
&#xD;
          -  Positive (past or current) or suspected Covid19 status (cough, fever, suggestive&#xD;
             radiological images, etc.)&#xD;
&#xD;
          -  Lack of opposition to participating in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under legal protection&#xD;
&#xD;
          -  Covid19 status negative, (former or current) and not suspected&#xD;
&#xD;
          -  Patient unable to object&#xD;
&#xD;
          -  Patient with no social security care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura RUSCIO</last_name>
    <phone>+3301 45 21 34 41</phone>
    <email>laura.ruscio@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP, Bicêtre Hospital</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laura RUSCIO, MD, PhD</last_name>
      <phone>+33(0)1 45 21 34 41</phone>
      <email>laura.ruscio@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LAPAROSCOPY</keyword>
  <keyword>pneumoperitoneum</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

